Skip to main content

Together we are beating cancer

Donate now

Improving treatments

Showing 12 out of 28 results
A Cancer Grand Challenges graphic announcing 9 new challenges
  • Science & Technology
  • Health & Medicine

Time to take on 9 new Cancer Grand Challenges

These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them. These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.

by Tim Gunn | News | 8 March 2023

8 March 2023

Glioblastoma cells seen through a microscope.

We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective. We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective.

by Tim Gunn | Analysis | 13 February 2023

13 February 2023

A woman receiving chemotherapy from a nurse.

Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded. Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded.

by Tim Gunn | News | 20 January 2023

20 January 2023

Headshots of Ruth Plummer, Eve Wiltshaw and Judith Bliss

As our 20th anniversary year draws to a close, we're celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more. As our 20th anniversary year draws to a close, we're celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

by Amy Warnock | In depth | 18 January 2023

18 January 2023

A packet of Viagra pills

Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect.  Researchers have found a drug that targets the tumour microenvironment that could improve treatment for certain cancers. But it might not be the kind of drug you expect. 

by Jacob Smith | Analysis | 21 June 2022

21 June 2022

Breast cancer tissue under the microscope.

A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women. A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.

by In collaboration with PA Media Group | News | 11 February 2022

11 February 2022

3D rendering of blood cancer
  • Science & Technology
  • Health & Medicine

Scientists trial new way to boost CAR T-cell therapy

Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that ‘reboots’ a treatment for some people with blood cancer whose cancer starts to come back. Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that ‘reboots’ a treatment for some people with blood cancer whose cancer starts to come back.

by Harry Jenkins | News | 23 June 2021

23 June 2021

White pills on a pink background

Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery. Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.

by Harry Jenkins | News | 26 May 2021

26 May 2021